ProCE Banner Activity

Integrating Weight Loss Medications, Lifestyle Changes, and Comprehensive Care for Optimal Obesity Management

Clinical Thought

In this commentary, experts emphasize the importance of integrating weight loss medications with lifestyle modifications, such as diet and exercise, to achieve optimal outcomes in obesity management. By focusing on a comprehensive care model that addresses both the pharmacologic and behavioral aspects of treatment, healthcare professionals can improve overall health, manage comorbidities, and enhance patients' quality of life.

Released: December 10, 2024

Expiration: December 09, 2025

Share

Faculty

Jaime Almandoz

Jaime Almandoz, MD, MBA, MRCPI, FTOS

Medical Director, Weight Wellness Program
Associate Professor of Internal Medicine
Division of Endocrinology
University of Texas Southwestern Medical Center
Dallas, Texas

Domenica M. Rubino

Domenica M. Rubino, MD

Director
Washington Center for Weight Management and Research
Arlington, Virginia

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

This activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc.

Disclosure

Primary Author

Jaime Almandoz, MD, MBA, MRCPI, FTOS

Medical Director, Weight Wellness Program
Associate Professor of Internal Medicine
Division of Endocrinology
University of Texas Southwestern Medical Center
Dallas, Texas

Jaime Almandoz, MD, MBA, MRCPI, FTOS: consultant/advisor/speaker: Boehringer Ingelheim, Lilly, Novo Nordisk, Wave Life Sciences.

Domenica M. Rubino, MD

Director
Washington Center for Weight Management and Research
Arlington, Virginia

Domenica M. Rubino, MD: consultant/advisor/speaker: AstraZeneca, Boehringer Ingelheim, Cytoki, Lilly, Novo Nordisk, Regeneron, Shionogi; researcher: Boehringer Ingelheim, Kallyope, Novo Nordisk; individual publicly traded stocks/stock options: Lilly.